Changeflow GovPing Healthcare & Life Sciences cDNA Library Interaction Testing Method, HuBei ...
Routine Rule Added Draft

cDNA Library Interaction Testing Method, HuBei Hongshan Laboratory

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

US Patent Application US20260109966A1, published April 23, 2026, discloses a method for preparing an interaction plasmid library and a method for testing interactions between cDNA libraries. The cDNA libraries are insertable into the first multiple cloning site and the second multiple cloning site of a dual expression vector for testing interactions between different cDNA libraries. Filed by HuBei Hongshan Laboratory (Application No. 19000135, filed December 23, 2024) with inventors Lin Li and Xiaoyang Shang.

“The cDNA libraries could be inserted into the first multiple cloning site and the second multiple cloning site of the dual expression vector for testing the interactions between the different cDNA libraries.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 264 changes logged to date.

What changed

US Patent Application US20260109966A1 (Kind A1) was published by the USPTO on April 23, 2026. The application discloses methods for preparing interaction plasmid libraries and methods for testing interactions between cDNA libraries, wherein cDNA libraries may be inserted into dual expression vectors to test interactions between different libraries.

Biotechnology researchers, pharmaceutical developers, and genetic engineering firms developing dual-expression vector systems or cDNA library screening technologies should monitor this application for its potential claims scope. If granted, the patent would give HuBei Hongshan Laboratory exclusivity over the described interaction testing methods, which may affect freedom-to-operate assessments for firms working in protein-protein interaction screening or dual-library testing.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHODS FOR PREPARING INTERACTION PLASMID LIBRARY AND TESTING INTERACTION BETWEEN cDNA LIBRARIES

Application US20260109966A1 Kind: A1 Apr 23, 2026

Assignee

HuBei Hongshan Laboratory

Inventors

Lin LI, Xiaoyang SHANG

Abstract

A method for preparing interaction plasmid library and a method for testing interactions between cDNA libraries are provided. The cDNA libraries could be inserted into the first multiple cloning site and the second multiple cloning site of the dual expression vector for testing the interactions between the different cDNA libraries.

CPC Classifications

C12N 15/1055 C12N 1/165 C12N 15/1086 C12N 15/70 C12N 15/81 C12Q 1/44 C12R 2001/19 C12R 2001/645 G01N 2333/922

Filing Date

2024-12-23

Application No.

19000135

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Draft
Change scope
Substantive
Document ID
US20260109966A1

Who this affects

Applies to
Manufacturers Pharmaceutical companies
Industry sector
3254.1 Biotechnology
Activity scope
Patent filing Biotechnology research Genetic engineering
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!